Trump Floats 250% Tariff on Drug Imports: A Blow to India’s Pharma Powerhouse?
U.S. President Donald Trump has once again turned to tariffs as his preferred policy lever—this time, targeting the global pharmaceutical supply chain. In a recent interview with CNBC, Trump announced that he may impose import tariffs on pharmaceuticals as high as 250%, a dramatic escalation from earlier proposals. “We want pharmaceuticals made in our country,” […]